{"summary": "new Aptima-format surveillance assay for the Finnish new variant of Chlamydia trachomatis. it sensitively and specifically detects FI-nvCT (23S rRNA gene C1515T mutation) but not wild-type (C1515) C. trachomatis strains. it uses target capture and transcription-mediated amplification chemistries on the automated Panther instrument. negative controls included in this analysis (n = 6), consisting of 10,000 copies/mL of wild type (C1515) C. trachomatis RNA, yielded S/CO ratio values ranging from 0.016 to 0.112 (mean: 0.044); positive controls (n = 6) consisting of 1,000 copies/mL of IVT RNA corresponding to FI-nvCT (C1515T) rRNA yielded S/CO ratio values ranging from 3.60 probit analysis of a panel of six positive and one negative FI-nvCT RNA samples established by Probit analysis. this analysis established the 95% limit of detection (LOD) for the assay is 231 copies/mL in Aptima sample transport medium and 210 copies/mL in urine sample matrix. all non-target organisms tested yielded negative results in the assay. isolates of C. trachomatis serotypes A, B, Ba, C, D, E, F, G, H, I, J, K, L1, L2 and L3 were tested at 1x105 IFU/mL each. all serotypes tested yielded negative results in the assay with S/CO ratio values ranging from 0.129 to 0.248. 1e6 CFU/mL Campylobacter jejuni 1e6 CFU/mL 4 Citrobacter koseri 1e6 CFU/mL 0/10 0.035 10/10 4.679 Corynebacterium diphtheria 1e6 CFU/mL Corynebacterium genitalium 1e6 CFU/mL 5 Eggerthella lenta 1e6 CFU/mL 0/10 0.050 10/10 s 1e6 CFU/mL 0/10 0.061 10/10 4.554 Megasphaera type 1 1e6 CFU/mL Mobiluncus curtisii 1e6 CFU/mL 10 Mycoplasma genitalium 1e6 CFU/mL 0/10 0.034 10/10 5.514 Mycoplasma hominis 1e6 CFU/mL Mycoplasma pneumoniae 1e4 CFU/mL Neisseri Burkholderia cepacia 1e6 CFU/mL 15 Clostridium difficile 1e6 CFU/mL 0/10 0.040 10/10 3.991 Prevotella bivia 1e6 CFU/mL Candida albicans 1e6 CFU/mL Candida albicans 1e6 CFU/mL 16 Entamoeba histolytica 1e4 cells/mL 0/10 0.052 10/10 3.963 Giard TCID50/mL 21 Norovirus Group II 1e6 TCID50/mL 0/10 0.082 10/10 3.592 Respiratory syncytial virus type B 1e5 TCID50/mL Rhinovirus A16 1e5 TCID50/mL 22 Chlamydia pneumoniae 1e5 IFU/mL 0/10 0.033 10/10 3.219 Chlamydia psittaci (GP 153 isolates of 14 non-N. gonorrhoeae Neisseria species and three Moraxella species; 10 Trichomonas vaginalis (TV samples); five reference strains of four non-TV Trichomonas species; 9 C. trachomatis strains of different genotypes. 428 clinical C. trachomatis wild type positive AC2 specimens; 23 clinical specimens positive for N. gonorrhoeae flava 1 0 1 N. flavescens 90 0 90 N. lactamica 12 0 12 N. macacae 17 0 17 N. mucosa 18 0 18 N. oralis 1 0 1 N. perflava 62 0 62 N. sicca 9 0 9 N. subflava 6 0 6 N. meningitidis a 17 0 17 Moraxella catarrhalis 1 0 1 M. nonlique a new study presents validation and verification data for a new research-use Aptima-format NAAT for detection of the FI-nvCT strain. the assay selectively detects with high sensitivity (100%) and specificity (100%) C. trachomatis strains containing 23S rRNA with the C1515T mutation found to be the root cause of compromised detection. the automated research-use only Aptima-format FI-nvCT surveillance test should facilitate the rapid completion of epidemiologic surveillance studies."}